Sequana Medical N.V. Logo

Sequana Medical N.V.

Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.

SEQUA | BR

Overview

Corporate Details

ISIN(s):
BE0974340722
LEI:
8755009AN12Y4PEOII07
Country:
Belgium
Address:
Kortrijksesteenweg 1112 B 102, 9051 Gent
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Sequana Medical N.V. is a commercial-stage medical device company pioneering innovative treatments for drug-resistant fluid overload. The company's lead product is the alfapump®, a proprietary, fully-implanted, and wirelessly charged system that automatically and continuously moves excess abdominal fluid (ascites) to the bladder for natural elimination. The alfapump® is the first U.S. FDA-approved active implantable device for treating recurrent or refractory ascites due to liver cirrhosis, and it also holds a CE mark in Europe. The system is designed to significantly reduce or eliminate the need for invasive therapeutic paracentesis procedures and improve patient quality of life. Sequana Medical is also developing its DSR® (Direct Sodium Removal) therapy platform to manage fluid overload in patients with heart failure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 18:30
Major Shareholding Notification
2025-11-13 Transparency Notification BlackRock.pdf
English 284.9 KB
2025-11-24 18:30
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (24 November 20…
English 296.1 KB
2025-11-24 18:30
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (24 November 202…
Dutch 311.7 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (ENG) 14 November 2025.…
English 276.3 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (NL) 14 November 2025.p…
Dutch 289.5 KB
2025-08-14 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
English 289.7 KB
2025-08-14 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
Dutch 317.1 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
English 232.0 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Dutch 252.2 KB
2025-07-28 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
English 287.8 KB
2025-07-28 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
Dutch 314.8 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
English 270.9 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Dutch 296.4 KB
2025-07-09 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (9 July 2025).p…
English 706.3 KB
2025-07-09 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (9 July 2025).pdf
Dutch 711.7 KB

Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sequana Medical N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-06-04 Fin-2K BV Executive member Buy 16,000 N/A
2021-05-27 Crosbie Ian Board Buy 32,000 N/A
2020-09-07 Fin-2K BV Executive member Buy 20,036 N/A
2020-09-04 Crosbie Ian Board Buy 40,073 N/A
2019-06-06 wim ottevaere Board Buy 4,000 25,600.00 EUR
2019-03-29 Fin-2K BV Executive member Buy 20,383 N/A
2019-03-06 Crosbie Ian Board Buy 40,766 N/A
2019-02-26 Chauvineau Pierre Board Buy 10,192 N/A
2019-02-13 wim ottevaere Board Buy 7,000 49,345.10 EUR

Peer Companies

Biohit Oyj Logo
Develops diagnostic tests and lab systems for healthcare, research, and industrial laboratories.
Finland
BIOBV
BIOLIFE SOLUTIONS INC Logo
Develops bioproduction tools and services for the cell and gene therapy industry.
United States of America
BLFS
BIONEERCORPORATION Logo
Provides molecular biology tools & diagnostic kits for research and clinical applications.
South Korea
064550
BioNote, Inc. Logo
Manufactures veterinary diagnostics, analyzers, and software for animal health professionals.
South Korea
377740
Develops & manufactures HA-based biomaterials & medical devices for aesthetics & medical sectors.
South Korea
099430
BIO-RAD LABORATORIES, INC. Logo
Develops and manufactures products for life science research and clinical diagnostic markets.
United States of America
BIO
Bioretec Oy Logo
Develops bioabsorbable orthopedic implants for adults & children, eliminating removal surgery.
Finland
BRETEC
Bioventus Inc. Logo
Offers orthobiologics, pain treatments, and surgical solutions for active healing.
United States of America
BVS
Bluejay Diagnostics, Inc. Logo
Develops rapid, automated diagnostic systems for critical care in hospitals and clinics.
United States of America
BJDX
Boditech Med Inc. Logo
Develops & manufactures rapid point-of-care in-vitro diagnostic solutions for medical pros.
South Korea
206640

Talk to a Data Expert

Have a question? We'll get back to you promptly.